a public good project by the
Synthesis
Company
of California

© 2026

Alizon M. Riou-Eymard | doi.page

0 works0 citations0 h-index

Google Scholar OpenAlex

Alizon M. Riou-Eymard

GlaxoSmithKline (France)(FR)

Research Areas

Multiple Myeloma Research and Treatments, Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors

Most-Cited Works

→ The Discovery of I-BET726 (GSK1324726A), a Potent Tetrahydroquinoline ApoA1 Up-Regulator and Selective BET Bromodomain Inhibitor(2014)187 cited